ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Luciferin Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-25E16751
Home | Market Reports | Science| Biological Sciences
Global Luciferin Market Research Report 2024
BUY CHAPTERS

Global Luciferin Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-25E16751
Report
November 2025
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MyBioSource
Promega
Abcam
RayBiotech
G-Biosciences
Biorbyt
Tocris Bioscience
Biotium
AAT Bioquest

Luciferin Market

The global Luciferin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Luciferin is a compound that plays a vital role in bioluminescence, a natural phenomenon where living organisms produce light. It is a light-emitting molecule that reacts with the enzyme luciferase in the presence of oxygen and ATP to generate light. Luciferin is commonly used in bioluminescence-based assays and imaging techniques to study various biological processes, such as gene expression, cell proliferation, and protein interactions. Its ability to produce light without external sources makes it a valuable tool in scientific research and medical diagnostics.
The industry trend for Luciferin is experiencing growth due to the increasing demand for bioluminescent assays in drug discovery, molecular biology research, and medical diagnostics. Luciferin-based technologies are widely used in imaging techniques that enable real-time visualization of biological processes in living cells and tissues. As pharmaceutical companies and research institutions focus on developing new drugs and understanding complex biological mechanisms, the demand for Luciferin and related products is expected to continue rising. Ongoing advancements in bioluminescence technology are also driving the expansion of the Luciferin market for various research and diagnostic applications.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Luciferin market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Luciferin Market Report

Report Metric Details
Report Name Luciferin Market
Segment by Type
  • Liquid
  • Solid
Segment by Application
  • Laboratory
  • Hospital
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MyBioSource, Promega, Abcam, RayBiotech, G Biosciences, Biorbyt, Tocris Bioscience, Biotium, AAT Bioquest
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Luciferin study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Luciferin Market report?

Ans: The main players in the Luciferin Market are MyBioSource, Promega, Abcam, RayBiotech, G Biosciences, Biorbyt, Tocris Bioscience, Biotium, AAT Bioquest

What are the Application segmentation covered in the Luciferin Market report?

Ans: The Applications covered in the Luciferin Market report are Laboratory, Hospital, Others

What are the Type segmentation covered in the Luciferin Market report?

Ans: The Types covered in the Luciferin Market report are Liquid, Solid

1 Study Coverage
1.1 Introduction to Luciferin: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Luciferin Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Liquid
1.2.3 Solid
1.3 Market Segmentation by Application
1.3.1 Global Luciferin Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Luciferin Revenue Estimates and Forecasts 2020-2031
2.2 Global Luciferin Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Luciferin Sales Estimates and Forecasts 2020-2031
2.4 Global Luciferin Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Luciferin Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Luciferin Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Luciferin Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Liquid Market Size by Manufacturers
4.5.2 Solid Market Size by Manufacturers
4.6 Global Luciferin Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Luciferin Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Luciferin Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Luciferin Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Luciferin Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Luciferin Sales and Revenue by Type (2020-2031)
7.4 North America Luciferin Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Luciferin Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Luciferin Sales and Revenue by Type (2020-2031)
8.4 Europe Luciferin Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Luciferin Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Luciferin Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Luciferin Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Luciferin Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Luciferin Sales and Revenue by Type (2020-2031)
10.4 Central and South America Luciferin Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Luciferin Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Luciferin Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Luciferin Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Luciferin Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 MyBioSource
12.1.1 MyBioSource Corporation Information
12.1.2 MyBioSource Business Overview
12.1.3 MyBioSource Luciferin Product Models, Descriptions and Specifications
12.1.4 MyBioSource Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 MyBioSource Luciferin Sales by Product in 2024
12.1.6 MyBioSource Luciferin Sales by Application in 2024
12.1.7 MyBioSource Luciferin Sales by Geographic Area in 2024
12.1.8 MyBioSource Luciferin SWOT Analysis
12.1.9 MyBioSource Recent Developments
12.2 Promega
12.2.1 Promega Corporation Information
12.2.2 Promega Business Overview
12.2.3 Promega Luciferin Product Models, Descriptions and Specifications
12.2.4 Promega Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Promega Luciferin Sales by Product in 2024
12.2.6 Promega Luciferin Sales by Application in 2024
12.2.7 Promega Luciferin Sales by Geographic Area in 2024
12.2.8 Promega Luciferin SWOT Analysis
12.2.9 Promega Recent Developments
12.3 Abcam
12.3.1 Abcam Corporation Information
12.3.2 Abcam Business Overview
12.3.3 Abcam Luciferin Product Models, Descriptions and Specifications
12.3.4 Abcam Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Abcam Luciferin Sales by Product in 2024
12.3.6 Abcam Luciferin Sales by Application in 2024
12.3.7 Abcam Luciferin Sales by Geographic Area in 2024
12.3.8 Abcam Luciferin SWOT Analysis
12.3.9 Abcam Recent Developments
12.4 RayBiotech
12.4.1 RayBiotech Corporation Information
12.4.2 RayBiotech Business Overview
12.4.3 RayBiotech Luciferin Product Models, Descriptions and Specifications
12.4.4 RayBiotech Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 RayBiotech Luciferin Sales by Product in 2024
12.4.6 RayBiotech Luciferin Sales by Application in 2024
12.4.7 RayBiotech Luciferin Sales by Geographic Area in 2024
12.4.8 RayBiotech Luciferin SWOT Analysis
12.4.9 RayBiotech Recent Developments
12.5 G Biosciences
12.5.1 G Biosciences Corporation Information
12.5.2 G Biosciences Business Overview
12.5.3 G Biosciences Luciferin Product Models, Descriptions and Specifications
12.5.4 G Biosciences Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 G Biosciences Luciferin Sales by Product in 2024
12.5.6 G Biosciences Luciferin Sales by Application in 2024
12.5.7 G Biosciences Luciferin Sales by Geographic Area in 2024
12.5.8 G Biosciences Luciferin SWOT Analysis
12.5.9 G Biosciences Recent Developments
12.6 Biorbyt
12.6.1 Biorbyt Corporation Information
12.6.2 Biorbyt Business Overview
12.6.3 Biorbyt Luciferin Product Models, Descriptions and Specifications
12.6.4 Biorbyt Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Biorbyt Recent Developments
12.7 Tocris Bioscience
12.7.1 Tocris Bioscience Corporation Information
12.7.2 Tocris Bioscience Business Overview
12.7.3 Tocris Bioscience Luciferin Product Models, Descriptions and Specifications
12.7.4 Tocris Bioscience Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Tocris Bioscience Recent Developments
12.8 Biotium
12.8.1 Biotium Corporation Information
12.8.2 Biotium Business Overview
12.8.3 Biotium Luciferin Product Models, Descriptions and Specifications
12.8.4 Biotium Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Biotium Recent Developments
12.9 AAT Bioquest
12.9.1 AAT Bioquest Corporation Information
12.9.2 AAT Bioquest Business Overview
12.9.3 AAT Bioquest Luciferin Product Models, Descriptions and Specifications
12.9.4 AAT Bioquest Luciferin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 AAT Bioquest Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Luciferin Industry Chain
13.2 Luciferin Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Luciferin Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Luciferin Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Luciferin Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Luciferin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
MyBioSource
Promega
Abcam
RayBiotech
G-Biosciences
Biorbyt
Tocris Bioscience
Biotium
AAT Bioquest
List of Tables
 Table 1. Global Luciferin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Luciferin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Luciferin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Luciferin Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Luciferin Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Luciferin Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Luciferin Sales by Region (2020-2025) & (Tons)
 Table 8. Global Luciferin Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Luciferin Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Luciferin Production by Region (2020-2025) & (Tons)
 Table 12. Global Luciferin Production by Region (2026-2031) & (Tons)
 Table 13. Global Luciferin Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Luciferin Sales Share by Manufacturers (2020-2025)
 Table 15. Global Luciferin Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Luciferin Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Luciferin by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Luciferin as of 2024)
 Table 19. Global Luciferin Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Luciferin Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
 Table 21. Key Manufacturers Luciferin Manufacturing Base and Headquarters
 Table 22. Global Luciferin Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Luciferin Sales by Type (2020-2025) & (Tons)
 Table 26. Global Luciferin Sales by Type (2026-2031) & (Tons)
 Table 27. Global Luciferin Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Luciferin Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Luciferin ASP by Type (2020-2031) & (US$/kg)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Luciferin Sales by Application (2020-2025) & (Tons)
 Table 32. Global Luciferin Sales by Application (2026-2031) & (Tons)
 Table 33. Luciferin High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Luciferin Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Luciferin Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Luciferin ASP by Application (2020-2031) & (US$/kg)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Luciferin Growth Accelerators and Market Barriers
 Table 40. North America Luciferin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Luciferin Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Luciferin Growth Accelerators and Market Barriers
 Table 43. Europe Luciferin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Luciferin Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Luciferin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Luciferin Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Luciferin Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Luciferin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Luciferin Investment Opportunities and Key Challenges
 Table 50. Central and South America Luciferin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Luciferin Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Luciferin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. MyBioSource Corporation Information
 Table 54. MyBioSource Description and Major Businesses
 Table 55. MyBioSource Product Models, Descriptions and Specifications
 Table 56. MyBioSource Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 57. MyBioSource Sales Value Proportion by Product in 2024
 Table 58. MyBioSource Sales Value Proportion by Application in 2024
 Table 59. MyBioSource Sales Value Proportion by Geographic Area in 2024
 Table 60. MyBioSource Luciferin SWOT Analysis
 Table 61. MyBioSource Recent Developments
 Table 62. Promega Corporation Information
 Table 63. Promega Description and Major Businesses
 Table 64. Promega Product Models, Descriptions and Specifications
 Table 65. Promega Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 66. Promega Sales Value Proportion by Product in 2024
 Table 67. Promega Sales Value Proportion by Application in 2024
 Table 68. Promega Sales Value Proportion by Geographic Area in 2024
 Table 69. Promega Luciferin SWOT Analysis
 Table 70. Promega Recent Developments
 Table 71. Abcam Corporation Information
 Table 72. Abcam Description and Major Businesses
 Table 73. Abcam Product Models, Descriptions and Specifications
 Table 74. Abcam Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 75. Abcam Sales Value Proportion by Product in 2024
 Table 76. Abcam Sales Value Proportion by Application in 2024
 Table 77. Abcam Sales Value Proportion by Geographic Area in 2024
 Table 78. Abcam Luciferin SWOT Analysis
 Table 79. Abcam Recent Developments
 Table 80. RayBiotech Corporation Information
 Table 81. RayBiotech Description and Major Businesses
 Table 82. RayBiotech Product Models, Descriptions and Specifications
 Table 83. RayBiotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 84. RayBiotech Sales Value Proportion by Product in 2024
 Table 85. RayBiotech Sales Value Proportion by Application in 2024
 Table 86. RayBiotech Sales Value Proportion by Geographic Area in 2024
 Table 87. RayBiotech Luciferin SWOT Analysis
 Table 88. RayBiotech Recent Developments
 Table 89. G Biosciences Corporation Information
 Table 90. G Biosciences Description and Major Businesses
 Table 91. G Biosciences Product Models, Descriptions and Specifications
 Table 92. G Biosciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. G Biosciences Sales Value Proportion by Product in 2024
 Table 94. G Biosciences Sales Value Proportion by Application in 2024
 Table 95. G Biosciences Sales Value Proportion by Geographic Area in 2024
 Table 96. G Biosciences Luciferin SWOT Analysis
 Table 97. G Biosciences Recent Developments
 Table 98. Biorbyt Corporation Information
 Table 99. Biorbyt Description and Major Businesses
 Table 100. Biorbyt Product Models, Descriptions and Specifications
 Table 101. Biorbyt Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 102. Biorbyt Recent Developments
 Table 103. Tocris Bioscience Corporation Information
 Table 104. Tocris Bioscience Description and Major Businesses
 Table 105. Tocris Bioscience Product Models, Descriptions and Specifications
 Table 106. Tocris Bioscience Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 107. Tocris Bioscience Recent Developments
 Table 108. Biotium Corporation Information
 Table 109. Biotium Description and Major Businesses
 Table 110. Biotium Product Models, Descriptions and Specifications
 Table 111. Biotium Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 112. Biotium Recent Developments
 Table 113. AAT Bioquest Corporation Information
 Table 114. AAT Bioquest Description and Major Businesses
 Table 115. AAT Bioquest Product Models, Descriptions and Specifications
 Table 116. AAT Bioquest Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 117. AAT Bioquest Recent Developments
 Table 118. Key Raw Materials Distribution
 Table 119. Raw Materials Key Suppliers
 Table 120. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 121. Milestones in Production Technology Evolution
 Table 122. Distributors List
 Table 123. Market Trends and Market Evolution
 Table 124. Market Drivers and Opportunities
 Table 125. Market Challenges, Risks, and Restraints
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources


List of Figures
 Figure 1. Luciferin Product Picture
 Figure 2. Global Luciferin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Liquid Product Picture
 Figure 4. Solid Product Picture
 Figure 5. Global Luciferin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Laboratory
 Figure 7. Hospital
 Figure 8. Others
 Figure 9. Luciferin Report Years Considered
 Figure 10. Global Luciferin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Luciferin Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Luciferin Revenue Market Share by Region (2020-2031)
 Figure 14. Global Luciferin Sales (2020-2031) & (Tons)
 Figure 15. Global Luciferin Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global Luciferin Sales Market Share by Region (2020-2031)
 Figure 17. Global Luciferin Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 18. Global Luciferin Production Trend by Region (2020-2031) (Tons)
 Figure 19. Global Luciferin Production Market Share by Region (2020-2031)
 Figure 20. Production Capacity Enablers & Constraints
 Figure 21. Luciferin Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 22. Luciferin Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 23. Luciferin Production Growth Rate in China (2020-2031) & (Tons)
 Figure 24. Luciferin Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 25. Top 5 and Top 10 Manufacturers Luciferin Sales Volume Market Share in 2024
 Figure 26. Global Luciferin Revenue Market Share Ranking (2024)
 Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 28. Liquid Revenue Market Share by Manufacturer in 2024
 Figure 29. Solid Revenue Market Share by Manufacturer in 2024
 Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 32. Global Luciferin Sales Market Share by Type (2020-2031)
 Figure 33. Global Luciferin Revenue Market Share by Type (2020-2031)
 Figure 34. Global Luciferin Sales Market Share by Application (2020-2031)
 Figure 35. Global Luciferin Revenue Market Share by Application (2020-2031)
 Figure 36. North America Luciferin Sales YoY (2020-2031) & (Tons)
 Figure 37. North America Luciferin Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. North America Top 5 Manufacturers Luciferin Sales Revenue (US$ Million) in 2024
 Figure 39. North America Luciferin Sales Volume (Tons) by Type (2020- 2031)
 Figure 40. North America Luciferin Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 41. North America Luciferin Sales Volume (Tons) by Application (2020-2031)
 Figure 42. North America Luciferin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. US Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 44. Canada Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 45. Mexico Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe Luciferin Sales YoY (2020-2031) & (Tons)
 Figure 47. Europe Luciferin Revenue YoY (2020-2031) & (US$ Million)
 Figure 48. Europe Top 5 Manufacturers Luciferin Sales Revenue (US$ Million) in 2024
 Figure 49. Europe Luciferin Sales Volume (Tons) by Type (2020-2031)
 Figure 50. Europe Luciferin Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 51. Europe Luciferin Sales Volume (Tons) by Application (2020-2031)
 Figure 52. Europe Luciferin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Germany Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 54. France Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 55. U.K. Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 56. Italy Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 57. Russia Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 58. Asia-Pacific Luciferin Sales YoY (2020-2031) & (Tons)
 Figure 59. Asia-Pacific Luciferin Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Top 8 Manufacturers Luciferin Sales Revenue (US$ Million) in 2024
 Figure 61. Asia-Pacific Luciferin Sales Volume (Tons) by Type (2020- 2031)
 Figure 62. Asia-Pacific Luciferin Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 63. Asia-Pacific Luciferin Sales Volume (Tons) by Application (2020-2031)
 Figure 64. Asia-Pacific Luciferin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 65. Indonesia Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 66. Japan Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 67. South Korea Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 68. China Taiwan Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 69. India Luciferin Revenue (2020-2031) & (US$ Million)
 Figure 70. Central and South America Luciferin Sales YoY (2020-2031) & (Tons)
 Figure 71. Central and South America Luciferin Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Central and South America Top 5 Manufacturers Luciferin Sales Revenue (US$ Million) in 2024
 Figure 73. Central and South America Luciferin Sales Volume (Tons) by Type (2021-2031)
 Figure 74. Central and South America Luciferin Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Central and South America Luciferin Sales Volume (Tons) by Application (2020-2031)
 Figure 76. Central and South America Luciferin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. Brazil Luciferin Revenue (2020-2025) & (US$ Million)
 Figure 78. Argentina Luciferin Revenue (2020-2025) & (US$ Million)
 Figure 79. Middle East, and Africa Luciferin Sales YoY (2020-2031) & (Tons)
 Figure 80. Middle East and Africa Luciferin Revenue YoY (2020-2031) & (US$ Million)
 Figure 81. Middle East and Africa Top 5 Manufacturers Luciferin Sales Revenue (US$ Million) in 2024
 Figure 82. Middle East and Africa Luciferin Sales Volume (Tons) by Type (2021-2031)
 Figure 83. South America Luciferin Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 84. Middle East and Africa Luciferin Sales Volume (Tons) by Application (2020-2031)
 Figure 85. Middle East and Africa Luciferin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 86. GCC Countries Luciferin Revenue (2020-2025) & (US$ Million)
 Figure 87. Turkey Luciferin Revenue (2020-2025) & (US$ Million)
 Figure 88. Egypt Luciferin Revenue (2020-2025) & (US$ Million)
 Figure 89. South Africa Luciferin Revenue (2020-2025) & (US$ Million)
 Figure 90. Luciferin Industry Chain Mapping
 Figure 91. Regional Luciferin Manufacturing Base Distribution (%)
 Figure 92. Luciferin Production Process
 Figure 93. Regional Luciferin Production Cost Structure
 Figure 94. Channels of Distribution (Direct Vs Distribution)
 Figure 95. Bottom-up and Top-down Approaches for This Report
 Figure 96. Data Triangulation
 Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Luciferase Assay Market Research Report 2024
Global Anti Luciferase Antibody Market Research Report 2025
Global Luciferase Antibody Market Research Report 2024
D Luciferin Substrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luciferase Substrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Luciferase Assay Reagent Market Research Report 2025
Global Luciferase Monoclonal Antibody Market Research Report 2024
Global Luciferase Assay System Market Research Report 2025
Global Luciferase Detection Reagent Market Research Report 2025
Luciferase Glow Assay Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Luciferase Assay Kits Market Research Report 2024
Global Luminol Market Research Report 2025
Global D Luciferin Potassium Reagent Market Research Report 2025
Global In Vivo Bioluminescent Imaging System Market Research Report 2024
Global Luminescent Substrates Market Research Report 2025
Luciferase Assay Lysis Buffer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tube Luminometers Market Research Report 2024
Global Luminescence Detectors Market Insights Forecast to 2030
Firefly Luciferase Assay Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fluorescent Biosensor Market Research Report 2024

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions